You are here: Industry Insights > Lambda

News List

Eiger Announces Positive Results of COVID-19 Trial americanpharmaceuticalreview
October 22, 2020
Eiger BioPharmaceuticals announced results of the ILIAD Study (Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19), an investigator sponsored randomized trial of Peginterferon Lambda (Lambda) in outpatients with ...
Eiger Announces Results of Study in Patients with Mild, Uncomplicated COVID-19 americanpharmaceuticalreview
October 09, 2020
Eiger BioPharmaceuticals announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19 prnewswire
September 30, 2020
Eiger BioPharmaceuticals, Inc. announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
Novum Expands Services in North America contractpharma
July 23, 2020
Novum Pharmaceutical Research Services is expanding its services in North America by consolidating Lambda Therapeutic Research's Toronto, Canada clinic and bioanalytical laboratory into Novum operations.
Eiger Announces First COVID-19 Patients Dosed with Peginterferon Lambda americanpharmaceuticalreview
May 05, 2020
Eiger BioPharmaceuticals announced the first patients have been dosed in a Phase 2 study of peginterferon lambda (Lambda) in outpatients with mild COVID-19 at the Stanford University School of Medicine.